Lobbying client

CIRCASSIA PHARMACEUTICALS

Specialty pharmaceutical company

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
6
Filed by
2
Reported in-house
—
Reported by firms
$10,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2019 to 2020

Filings

6 filings, newest first.
Filing Filed by Amount
1st Quarter - Termination
1st Quarter 2020
THE SPECTRUM GROUP — reported
4th Quarter - Report
4th Quarter 2019
THE SPECTRUM GROUP — reported
Registration
4th Quarter 2019
THE SPECTRUM GROUP — reported
4th Quarter - Termination (No Activity)
4th Quarter 2019
WINNING STRATEGIES WASHINGTON — reported
3rd Quarter - Report
3rd Quarter 2019
WINNING STRATEGIES WASHINGTON $10,000 reported
Registration
3rd Quarter 2019
WINNING STRATEGIES WASHINGTON — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
WINNING STRATEGIES WASHINGTON 2 $10,000
THE SPECTRUM GROUP 2 —

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Veterans VET 3
Defense DEF 3
Medicare/Medicaid MMM 2
Pharmacy PHA 1

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.